Dual antigen target-based immunotherapy for prostate cancer eliminates the growth of established tumors in mice

Cancer Statistics, 2010

(2010) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Targeted therapeutic approaches for hormone-refractory prostate cancer

(2010) Flora Stavridi et al.   CANCER TREATMENT REVIEWS

Presentation of tumour antigens by dendritic cells and challenges faced

(2010) Neil C Robson et al.   CURRENT OPINION IN IMMUNOLOGY

Current status of immunological therapies for prostate cancer

(2010) Emmanuel S Antonarakis et al.   CURRENT OPINION IN UROLOGY

Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer

(2010) Philip W. Kantoff et al.   JOURNAL OF CLINICAL ONCOLOGY

Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer

(2010) Philip W. Kantoff et al.   NEW ENGLAND JOURNAL OF MEDICINE

Immunotherapy for Prostate Cancer: An Emerging Treatment Modality

(2010) Charles G. Drake   UROLOGIC CLINICS OF NORTH AMERICA

Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trials of active cellular immunotherapy with sipuleucel-T in advanced prostate cancer

(2009) Celestia S. Higano et al.   CANCER

Phase I Clinical Trial of an Adenovirus/Prostate-Specific Antigen Vaccine for Prostate Cancer: Safety and Immunologic Results

(2009) D. M. Lubaroff et al.   CLINICAL CANCER RESEARCH

Phase II, Randomized, Placebo-Controlled Trial of Neoadjuvant Celecoxib in Men With Clinically Localized Prostate Cancer: Evaluation of Drug-Specific Biomarkers

(2009) Emmanuel S. Antonarakis et al.   JOURNAL OF CLINICAL ONCOLOGY

Immunotherapeutics in Development for Prostate Cancer

(2009) A. L. Harzstark et al.   ONCOLOGIST

Vaccination with recombinant adenoviruses and dendritic cells expressing prostate-specific antigens is effective in eliciting CTL and suppresses tumor growth in the experimental prostate cancer

(2009) Sol Kim et al.   PROSTATE

Review of clinical studies on dendritic cell-based vaccination of patients with malignant melanoma: assessment of correlation between clinical response and vaccine parameters

(2008) Lotte Engell-Noerregaard et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Prostate stem cell antigen: A prospective therapeutic and diagnostic target

(2008) Adam B. Raff et al.   CANCER LETTERS

Prostate Stem Cell Antigen Vaccination Induces a Long-term Protective Immune Response against Prostate Cancer in the Absence of Autoimmunity

(2008) M. de la Luz Garcia-Hernandez et al.   CANCER RESEARCH